These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 20104217

  • 1. Outcome following infliximab therapy in children with ulcerative colitis.
    Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    Am J Gastroenterol; 2010 Jun; 105(6):1430-6. PubMed ID: 20104217
    [Abstract] [Full Text] [Related]

  • 2. The natural history of corticosteroid therapy for ulcerative colitis in children.
    Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A, Otley A, Evans J, Pfefferkorn M, Rosh J, Rothbaum R, Kugathasan S, Mezoff A, Wyllie R, Tolia V, delRosario JF, Moyer MS, Oliva-Hemker M, Leleiko N, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1118-23. PubMed ID: 16820327
    [Abstract] [Full Text] [Related]

  • 3. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis.
    Fanjiang G, Russell GH, Katz AJ.
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):312-7. PubMed ID: 17325550
    [Abstract] [Full Text] [Related]

  • 4. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R.
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [Abstract] [Full Text] [Related]

  • 5. A review of infliximab use in ulcerative colitis.
    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [Abstract] [Full Text] [Related]

  • 6. Infliximab for ulcerative colitis in children and adolescents.
    McGinnis JK, Murray KF.
    J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529
    [Abstract] [Full Text] [Related]

  • 7. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M, Burgueño P, Iglesias E, Panés J, Muñoz F, Bastida G, Castro L, Jiménez C, Mendoza JL, Barreiro-de Acosta M, Senent SG, Gomollón F, Calvet X, García-Planella E, Gómez M, Hernández V, Hinojosa J, Mañosa M, Nyssen OP, Gisbert JP.
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [Abstract] [Full Text] [Related]

  • 8. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK, Uzcanga LF.
    Dig Surg; 2008 Jan; 25(5):383-6. PubMed ID: 19005257
    [Abstract] [Full Text] [Related]

  • 9. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL, Jewell DP, Travis SP.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1055-60. PubMed ID: 17439506
    [Abstract] [Full Text] [Related]

  • 10. Infliximab in the treatment of severe ulcerative colitis: a follow-up study.
    Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M.
    Eur Rev Med Pharmacol Sci; 2004 May 01; 8(5):235-7. PubMed ID: 15638237
    [Abstract] [Full Text] [Related]

  • 11. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A.
    Eur Rev Med Pharmacol Sci; 2004 May 01; 8(5):231-3. PubMed ID: 15638236
    [Abstract] [Full Text] [Related]

  • 12. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
    Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C.
    Aliment Pharmacol Ther; 2007 Sep 01; 26(5):747-56. PubMed ID: 17697208
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR.
    Am J Gastroenterol; 2002 Oct 01; 97(10):2577-84. PubMed ID: 12385442
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E, Mañosa M, Van Domselaar M, Gordillo J, Zabana Y, Cabré E, López San Román A, Domènech E.
    Dig Liver Dis; 2012 Mar 01; 44(3):206-10. PubMed ID: 22079262
    [Abstract] [Full Text] [Related]

  • 15. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.
    Zeisler B, Lerer T, Markowitz J, Mack D, Griffiths A, Bousvaros A, Keljo D, Rosh J, Evans J, Kappelman M, Otley A, Kay M, Grossman A, Saeed S, Carvalho R, Oliva-Hemker M, Faubion W, Sudel B, Pfefferkorn M, Ashai-Khan F, Leleiko N, Hyams J, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    J Pediatr Gastroenterol Nutr; 2013 Jan 01; 56(1):12-8. PubMed ID: 22847466
    [Abstract] [Full Text] [Related]

  • 16. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
    Dean KE, Hikaka J, Huakau JT, Walmsley RS.
    J Gastroenterol Hepatol; 2012 Mar 01; 27(3):487-92. PubMed ID: 22098019
    [Abstract] [Full Text] [Related]

  • 17. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response.
    Turner D, Mack D, Leleiko N, Walters TD, Uusoue K, Leach ST, Day AS, Crandall W, Silverberg MS, Markowitz J, Otley AR, Keljo D, Mamula P, Kugathasan S, Hyams J, Griffiths AM.
    Gastroenterology; 2010 Jun 01; 138(7):2282-91. PubMed ID: 20193683
    [Abstract] [Full Text] [Related]

  • 18. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A.
    Am J Gastroenterol; 2009 Feb 01; 104(2):437-43. PubMed ID: 19174792
    [Abstract] [Full Text] [Related]

  • 19. Impact of persistence with infliximab on hospitalizations in ulcerative colitis.
    Carter CT, Leher H, Smith P, Smith DB, Waters HC.
    Am J Manag Care; 2011 Jun 01; 17(6):385-92. PubMed ID: 21756009
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease.
    Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Otley A, Griffiths A, Moyer MS, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Hale S, Lerer T, Pediatric IBD Collaborative Research Group.
    Clin Gastroenterol Hepatol; 2006 Sep 01; 4(9):1124-9. PubMed ID: 16861053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.